Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

3,553 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
New knowledge of the mechanisms of sorafenib resistance in liver cancer.
Zhu YJ, Zheng B, Wang HY, Chen L. Zhu YJ, et al. Acta Pharmacol Sin. 2017 May;38(5):614-622. doi: 10.1038/aps.2017.5. Epub 2017 Mar 27. Acta Pharmacol Sin. 2017. PMID: 28344323 Free PMC article. Review.
Transarterial Chemoembolization: A Favorable Postoperative Management to Improve Prognosis of Hepatitis B Virus-associated Intrahepatic Cholangiocarcinoma after Surgical Resection.
Jeong S, Zheng B, Wang J, Chi J, Tong Y, Xia L, Xu N, Zhang J, Kong X, Gu J, Xia Q. Jeong S, et al. Int J Biol Sci. 2017 Sep 21;13(10):1234-1241. doi: 10.7150/ijbs.21149. eCollection 2017. Int J Biol Sci. 2017. PMID: 29104490 Free PMC article.
Nervous system and primary liver cancer.
Jeong S, Zheng B, Wang H, Xia Q, Chen L. Jeong S, et al. Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):286-292. doi: 10.1016/j.bbcan.2018.04.002. Epub 2018 Apr 13. Biochim Biophys Acta Rev Cancer. 2018. PMID: 29660379 Review.
Individualized precision treatment: Targeting TAM in HCC.
Li Z, Wu T, Zheng B, Chen L. Li Z, et al. Cancer Lett. 2019 Aug 28;458:86-91. doi: 10.1016/j.canlet.2019.05.019. Epub 2019 May 24. Cancer Lett. 2019. PMID: 31129147 Review.
Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma.
Zhu YJ, Zheng B, Luo GJ, Ma XK, Lu XY, Lin XM, Yang S, Zhao Q, Wu T, Li ZX, Liu XL, Wu R, Liu JF, Ge Y, Yang L, Wang HY, Chen L. Zhu YJ, et al. Theranostics. 2019 May 26;9(12):3526-3540. doi: 10.7150/thno.32796. eCollection 2019. Theranostics. 2019. PMID: 31281495 Free PMC article.
Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma.
Tang J, Sui CJ, Wang DF, Lu XY, Luo GJ, Zhao Q, Lian QY, Jeong S, Lin XM, Zhu YJ, Zheng B, Wu R, Wang Q, Liu XL, Liu JF, Xia Q, Wu G, Gu J, Wang HY, Chen L. Tang J, et al. Theranostics. 2020 Apr 6;10(12):5384-5397. doi: 10.7150/thno.41616. eCollection 2020. Theranostics. 2020. PMID: 32373219 Free PMC article.
3,553 results
Jump to page
Feedback